AccessibilityHelpAbout Us
Convatec Group Plc logo

Convatec Group Plc(LSE) CTEC

Market Cap£4.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2016)+19%
5 Year-2%
1 Year-6%
1 Month-5%
£2.18
+0.46%
+0.01Today
Convatec Group Plc last closing stock price
MetricPriceDate
Last closeGBX 218.402026-09-15
Convatec Group Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-1.36%GBX 221.402026-09-08
1 month-4.88%GBX 229.602026-08-14
3 month+6.43%GBX 205.202026-06-17
Year to date-10.2%GBX 243.202025-12-31
1 year-5.94%GBX 232.202025-09-15
3 year-2.59%GBX 224.202023-09-15
5 year-2.06%GBX 223.002021-09-16
Since inception+18.71%GBX 1.832016-10-26

Convatec Group Plc Financials at a Glance

Market Cap

£4.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$4.84B

Net Income (TTM)

$340.79M

EPS (TTM)

£0.05

P/E Ratio

47.16

Dividend

£0.06

Beta (Volatility)

-0.01 (Low)

Price

£2.18

Volume

4,274,899

Open

£2.16

Previous Close

£2.18

Daily Range

£2.15 - £2.20

52-Week Range

£1.93 - £2.59

Estimated Earnings Date

Feb 23, 2027

CTEC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Convatec Group Plc

ConvaTec Group Plc operates as a global medical technology company, specializing in the creation, production, and worldwide distribution of a diverse array of healthcare products. The company focuses on advanced wound care, ostomy care, and continence and critical care solutions, catering to various healthcare needs.

Products and Services
  • Advanced wound care products for managing acute and chronic wounds
  • Ostomy care devices and accessories for individuals with stomas
  • Continence and critical care solutions, including urinary catheters
Growth Outlook
  • Projected revenue growth driven by increasing demand for wound care solutions
  • Expansion into emerging markets to enhance market presence
  • Investment in R&D to innovate and diversify product offerings
Financial Highlights
  • Q2 2026 revenue of $1.22 billion, reflecting strong market demand
  • Net income of $53.6 million, indicating profitability and operational efficiency
  • TTM gross profit margin of 55.1%, showcasing effective cost management
ConvaTec Group Plc has established itself as a key player in the medical technology sector, with a robust portfolio that addresses critical healthcare needs. The company's focus on innovation and expansion positions it well for future growth, particularly in the wound care and ostomy markets. Recent financial performance highlights a solid revenue base and profitability, underscoring the effectiveness of its operational strategies. With ongoing investments in research and development, ConvaTec is poised to enhance its product offerings and capture additional market share, making it an intriguing option for potential investors.
AI Generated • Aug 20, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

10,910

CEO

Jonathan Peter Mason, MBA

Website

www.convatec.com

Headquarters

London, GL W2 6LG, GB

CTEC Financials

Key Financial Metrics (TTM)

Gross Margin

55.07%

Operating Margin

16.16%

Net Income Margin

4.99%

Return on Equity

8.40%

Return on Capital

13.68%

Return on Assets

3.26%

Earnings Yield

2.12%

Dividend Yield

2.57%

Payout Ratio

1.12%

Stock Overview

Market Cap

£4.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

1.93B

Volume

4.27M

Avg. Volume

7.70M

Financials (TTM)

Gross Profit

$2.69B

Operating Income

$756.81M

EBITDA

$1.20B

Operating Cash Flow

$860.11M

Capital Expenditure

-$319.20M

Free Cash Flow

$540.91M

Cash & ST Invst.

$99.51M

Total Debt

$1.75B

Convatec Group Plc Performance Analysis

Convatec Group Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 1,682,524,23113.5%
20232023-12-31USD 1,723,500,1212.4%
20242024-12-31USD 1,791,499,4093.9%
20252025-12-31USD 1,850,685,1993.3%
Convatec Group Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-315.6%
Q22025-06-300.3%
Q42025-12-317.2%
Q22026-06-30-3.4%
Convatec Group Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD 0.03-40.8%
20232023-12-31USD 0.05104.4%
20242024-12-31USD 0.0741.9%
20252025-12-31USD 0.07-9.9%
Convatec Group Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-12-3142.9%
Q22025-06-30-6.6%
Q42025-12-31-31.2%
Q22026-06-30-22.2%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$1.22B

+9.7%

Gross Profit

$663.52M

+6.3%

Gross Margin

54.30%

N/A

Market Cap

£4.21BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£385.52K

N/A

Employees

10,910

N/A

Net Income

$53.56M

-31.9%

EBITDA

$288.62M

+15.0%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$99.51M

+2.7%

Total Debt

$1.75B

+23.9%

Accounts Receivable

$458.37M

+33.4%

Inventory

$437.26M

+15.5%

Long Term Debt

$1.72B

+24.0%

Short Term Debt

$25.13M

+20.2%

Return on Assets

3.26%

N/A

Return on Invested Capital

12.22%

N/A

Free Cash Flow

-$55.54M

-342.5%

Operating Cash Flow

$71.41M

-2.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
HIK.LHikma Pharmaceuticals PLC
£15.57+0.84%
HCM.LHUTCHMED (China) Limited
£2.01+1.01%
SPI.LSpire Healthcare Group plc
£2.46-0.20%
AMS.LAdvanced Medical Solutions Group plc
£2.81+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
VEEAVeea
$5.71+149.34%
BITOProShares Trust - ProShares Bitcoin ETF
$10.23-3.58%
NVDANvidia
$212.17+0.57%
INTCIntel
$97.14-0.05%

Questions About CTEC

What is the current price of Convatec Group Plc?

Convatec Group Plc is trading at £2.18 per share.

What is the 52-week range for Convatec Group Plc?

Over the past 52 weeks, Convatec Group Plc has traded between £1.93 and £2.59.

How much debt does Convatec Group Plc have?

As of the most recent reporting period, Convatec Group Plc reported total debt of $1.13B.

How much cash does Convatec Group Plc have on hand?

Convatec Group Plc reported $55.76M in cash and cash equivalents in its most recent financial results.

What is Convatec Group Plc’s dividend yield?

Convatec Group Plc currently has a dividend yield of 2.57%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services